2 drug(s) with this reaction
404 total reports
Seizure has been reported as an adverse reaction across 2 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 404 adverse event reports mention seizure in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with seizure, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have seizure listed in their FDA adverse event reports, sorted by report count:
In addition to seizure, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
2 drug(s) manufactured by Amgen Inc have seizure listed in their FDA adverse event reports: BLINATUMOMAB, CINACALCET HYDROCHLORIDE.
There are a combined 404 reports of seizure across 2 Amgen Inc drug(s) in the FDA adverse event database.